about
Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individualsEvolving paradigms in the treatment of opioid-induced bowel dysfunctionClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionCentral nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide.Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer.Novel opioid antagonists for opioid-induced bowel dysfunction.Prevalence of narcotic bowel syndrome in opioid abusers in iran.Recent advances in the use of opioids for cancer painMethylnaltrexone in the treatment of opioid-induced constipationDifferences in the characteristics of tolerance to μ-opioid receptor agonists in the colon from wild type and β-arrestin2 knockout miceEfficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis.Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced ConstipationPharmacological challenges in chronic pancreatitis.Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy.A review of the clinical manifestations, pathophysiology and management of opioid bowel dysfunction and narcotic bowel syndromeLubiprostone for the treatment of opioid-induced bowel dysfunction.Validated tools for evaluating opioid-induced bowel dysfunction.Opioid-induced bowel dysfunction: pathophysiology and management.Gastrointestinal motility problems in critical care: a clinical perspective.Gastrointestinal dysmotility disorders in critically ill dogs and cats.Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.Opioid-induced constipation in intensive care patients: relief in sight?Concomitant Opioid and Laxative Use in Older Adults in Hospice Care in the United States: 2007.Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.Opioid-induced constipation reversal in response to placebo in a patient with a history of IBS receiving methadone maintenance therapy.Reliability and validity of the Bowel Function Index for evaluating opioid-induced constipation: translation, cultural adaptation and validation of the Portuguese version (BFI-P).The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use.Association between initial morphine intake and body weight change, acoustic startle reflex and drug seeking in rats.Safety, tolerability, and pharmacokinetics of multiple ascending doses of naloxegol.Adjusting Bowel Regimens When Prescribing Opioids in Women Receiving Palliative Care in the Acute Care Setting.European Perspectives on Pain And Palliative Care
P2860
Q26745747-71044F54-2D26-4C26-B80C-646CF752689EQ26777692-CEABD73A-3864-4829-A672-CDDB6B47B234Q26995944-74B28D4B-BC61-4E1B-AD7B-BA985709F87BQ30384107-2EB925E0-C976-4AE0-A972-B39AA7E699A6Q33520508-A2F4D8B7-1502-4351-B944-AB651EEEBF69Q33715430-52FE7B0A-72D7-4105-BE07-7B4997431935Q34170592-3A7671EA-7DD1-4CA7-9055-925D1C8E43B4Q34191604-A4864ECE-23CE-4511-8EA7-FF17A525B40DQ34401446-5F8EF83B-852B-4757-AE40-189B3C6D8371Q34418203-6BF788A6-74F4-4D67-B96D-ED606EF25D2DQ35026245-6428C1D1-3250-45AB-921A-36B23857DDD9Q35980825-6D4B23D8-6579-4189-AFC1-44C17BB7DF98Q36384732-B2B49891-79F1-4CBF-A397-FF5BFDDF7773Q37233788-5181E5EF-820C-41AF-ADC7-B4D182E5DEB9Q37317436-60B8FFBA-3DD3-489C-BE7F-745EC065819DQ37603682-3D3806F1-EBCE-44D2-BB59-D721A5BCC55BQ37733993-024393C2-08D0-499F-9097-FF2B270AB550Q37850804-C586AB3A-9E4E-499A-A118-5F17DADF7C49Q37857765-33C128A1-2861-4862-B09F-07684DF7CD7AQ38040843-713FDF0C-3D1E-41E3-B5C0-75E8B6982522Q38199778-BA8B4EC1-0598-470B-83A6-9D38A3F171EFQ38715379-094E4BBE-D41A-48AD-B382-2F1E3C3155D7Q39051851-209BA392-8837-4123-B341-6B6294A0805DQ39317602-75198278-A61A-4641-AFEB-82813CA9BB65Q39375995-36E5FB92-7DDF-4128-8769-7DECD4F4D204Q43062741-D074365B-73A7-44F5-9F8F-CB069878906EQ43162368-0797C338-A047-4D0F-BB0A-260B4A7D811CQ43357590-A90BCA16-7561-4895-B568-0C4BA841C4C0Q44331888-42A29EA9-B9AD-435C-9CFC-87614EF3BE40Q47173491-E954C0D9-69EB-4FE4-8549-8B5BCB56FAF0Q50902698-784889DC-D3D4-4022-A01F-F6C27ADB5601Q50916743-EC9CBF18-C181-4651-9D96-949B9D3E5A2CQ57878978-40659726-51B4-4CD8-A190-46E065A31F49
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Opioid-induced bowel dysfunction.
@en
type
label
Opioid-induced bowel dysfunction.
@en
prefLabel
Opioid-induced bowel dysfunction.
@en
P1476
Opioid-induced bowel dysfunction.
@en
P2093
Jay Thomas
P304
P356
10.1016/J.JPAINSYMMAN.2007.01.017
P577
2007-11-05T00:00:00Z